# Renhai Chen

> Renhai Chen is a Series A investor at Ennovation Ventures backing Medical. See 4 investments, round sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Firm: [Ennovation Ventures](https://shizune.co/investors/profile/ennovation-ventures)
- Total investments: 4
- Last investment: Oct 2026
- Lead investor: 50%
- Last updated: Oct 2026

Renhai Chen is a Founding Partner of Ennovation Ventures.

## Contacts

5 contacts available for Renhai Chen: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/renhai-chen?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 75% |
| Biotechnology | 2 | 50% |
| Pharmaceutical | 2 | 50% |
| Genetics | 1 | 25% |
| Health Care | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Seed | 1 | 25% |
| Series B | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GenMedicn Biopharma | GenMedicn is a gene therapy drug development company dedicated to popularizing gene therapy drugs to normalized application scenarios. |  | Series A | Oct 07, 2026 | https://genmedicn.com/ |
| Zenshine Pharma | Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases. |  | Series B | Mar 11, 2023 | http://cn.zenshine-pharma.com/ |
| Human Zhizao | Human Intelligent Manufacturing is a fully automatic multiple flow fluorescence platform. |  | Seed | Mar 21, 2022 | http://humadx.com.cn/ |
| InxMed | InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $19M | Series A | Sep 04, 2020 | http://en.inxmed.com/ |

4 of 4 investments shown.

## Co-investors
- Broadcom Capital — VC Fund, 1 deal together
- [China Growth Capital](https://shizune.co/investors/profile/china-growth-capital) — VC Fund, 1 deal together
- [Cybernaut Venture Capital](https://shizune.co/investors/profile/cybernaut-venture-capital) — VC Fund, 1 deal together
- [Enran Chuangtou](https://shizune.co/investors/profile/enran-chuangtou) — VC Fund, 1 deal together
- [Grand Yangtze Capital](https://shizune.co/investors/profile/grand-yangtze-capital) — VC Fund, 1 deal together
- [Hankang Capital](https://shizune.co/investors/profile/hankang-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [SOSV SF & NY (Fka IndieBio)](https://shizune.co/investors/profile/synbio-axlr8r) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in China](https://shizune.co/investors/medical-angel-investors-china)
- [Biotechnology Angel Investors in China](https://shizune.co/investors/biotechnology-angel-investors-china)
- [Biotech Angel Investors in China](https://shizune.co/investors/biotech-angel-investors-china)

## FAQ

### What does Renhai Chen invest in?

Renhai Chen invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Renhai Chen?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Renhai Chen last invest?

The most recent investment recorded for Renhai Chen closed in Oct 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co